AI assistant
Gossamer Bio, Inc. — Director's Dealing 2021
May 5, 2021
32603_dirs_2021-05-05_3d2d17cd-7a5e-4f54-8dad-3793838c4ca5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2021-05-03
Reporting Person: Carter Laura (Chief Scientific Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 61863 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.37 | 2029-04-17 | Common Stock (110000.0) | Direct | |
| Stock Option (Right to Buy) | $16.4 | 2029-12-23 | Common Stock (13750.0) | Direct | |
| Stock Option (Right to Buy) | $14.55 | 2030-02-14 | Common Stock (34175.0) | Direct | |
| Stock Option (Right to Buy) | $9.79 | 2031-02-25 | Common Stock (28250.0) | Direct |
Footnotes
F1: Includes 54,427 restricted stock unit awards, which will vest in accordance with the terms of each award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.
F2: 57,291 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on May 17, 2021 and the last day of each one-month period thereafter through April 17, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F3: 4,582 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on May 23, 2021 and the last day of each one-month period thereafter through December 23, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F4: 9,967 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on May 14, 2021 and the last day of each one-month period thereafterthrough February 14, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F5: 25% of the total number of shares subject to the option will vest on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.